Unlocking the Future: Predicting Malaria Vaccine Uptake and Likely Barriers in Nigeria

Download Article

DOI: 10.21522/TIJPH.2013.11.04.Art002

Authors : Odis Adaora Isabella, Ogbenna Ann, Adesina Adefunke Oyeniyi, Okafor Ukamaka, Nzedibe Okechi

Abstract:

Malaria vaccination was identified as a major effort to curb the Africa’s challenge of death amongst children under 5. As malaria vaccines are yet to be distributed in Nigeria, there is a debate on their acceptability, accessibility, and barriers to receiving them. This study was conducted to assess the uptake of the malaria vaccination, and its determinants among internet users in Nigeria. An online survey was conducted between July and August 2023 using a semi-structured questionnaire. It was set up using kobotoolbox forms and data were collected online. Data collected were analyzed using GNU PSPP. A total of 399 respondents participated in the study, with a mean age of 43.52 years (± 10.90). The majority of the respondents were young adults. The majority of our respondents (72.9%) have heard of the malaria vaccine while the majority said they would take the malaria vaccine if available (85.2%). The major source of information on the malaria vaccine was the internet (55.4%), health workers (51.9%), and media (Radio/Television/Posters/Billboards/Pamphlets) (44.9%). Malaria vaccination uptake had a significant positive association with the level of education and level of monthly income (p < 0.05 respectively). Lack of availability, information, knowledge, awareness, cost of a malaria vaccine, the long distance to get to vaccination centers were the leading barriers to vaccine uptake. This calls for key stakeholders to ensure that malaria vaccination sensitization is championed immediately in Nigeria and discouragement of the spread of conspiracy theories to eliminate the infodemic associated factors will reduce vaccine hesitancy and thereby increase malaria vaccination uptake in Nigeria.
Keywords: Barriers, Determinant, Malaria, Malaria vaccine, Uptake, Vaccine.

References:

[1] WHO, 2021, Malaria, https://www.who.int/news-room/fact-sheets/detail/malaria.

[2] Omolola Oyinkan Adeshina, Solomon Nyame, James Milner, Ai Milojevic, Kwaku Poku Asante, (2022), Barriers and facilitators to nationwide implementation of the malaria vaccine in Ghana, https://academic.oup.com/heapol/article/38/1/28/6694852?login=false.

[3] WHO, 2020, Vaccines-and-immunization, https://www.who.int/health-topics/vaccines-and-immunization.

[4] University of Oxford, 2021, Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal https://www.ox.ac.uk/news/2021-04-23-malaria-vaccine-becomes-first-achieve-who-specified-75-efficacy-goal.

[5] Makoge V, Maat H, Vaandrager L, Koelen M. Poverty-related diseases (PRDs): unravelling complexities in disease responses in Cameroon. Trop Med Health. 2017; 45: 2.

[6] Adaora Anyichie – Odis, Progress report review on Malaria vaccination clinical trials, https://www.linkedin.com/pulse/progress-report-review-malaria-vaccination-clinical-anyichie-odis.

[7] WHO, 2021, https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk.

[8] Yeboah D, Owusu-Marfo J, Agyeman YN. Predictors of malaria vaccine uptake among children 6-24 months in the Kassena Nankana Municipality in the Upper East Region of Ghana. Malar J. 2022 Nov 16;21(1):339. doi: 10.1186/s12936-022-04378-1. PMID: 36384655; PMCID: PMC9666942. https://pubmed.ncbi.nlm.nih.gov/36384655/.

[9] WHO, (2022), https://www.who.int/news-room/feature-stories/detail/learning-lessons-from-the-pilots--overcoming-knowledge-gaps-around-the-malaria-vaccine-schedule-in-support-of-vaccine-uptake.

[10] Hassan Mumtaz, Abdullah Nadeem, Wajeeha Bilal, Farrukh Ansar, Saira Saleem, Qaisar Ali Khan, Tamara Tango, Christopher Farkouh, Naod F. Belay, Ravina Verma (2023), Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review https://onlinelibrary.wiley.com/doi/full/10.1002/iid3.899.

[11] Aremu TO, Singhal C, Ajibola OA, Agyin-Frimpong E, Appiah-Num Safo AA, Ihekoronye MR, Nabirye SE, Okoro ON. Assessing Public Awareness of the Malaria Vaccine in Sub-Saharan Africa. Tropical Medicine and Infectious Disease. 2022; 7(9):215. https://doi.org/10.3390/tropicalmed7090215.

[12] Nationonline, 2014, Nigeria, https://www.nationsonline.org/oneworld/nigeria.htm

[13] Worldometers, 2023, Nigeria, https://www.worldometers.info/world-population/nigeria-population/.

[14] Araoye, M.O. (2003) Research methodology with statistics for health and social sciences, First edition Nathadex Publisher Ilorin Nigeria. Page 119.

[15] Odis, A. I., et al (2022), Epidemics and Vaccination Dilemma in Complex Networks: A Case Study of Kosefe and Shomolu Local Government Area Lagos Nigeria.

[16] Odis, A. I. (2021) Attitude, Knowledge, and Use of Self–Medication with Antibiotics by Outpatients of Gbagada General Hospital Gbagada Lagos.

[17] Bosun Tijjani et al, (2023) COVID-19 Vaccine Uptake and its Determinants: Findings From A Web-Based Survey in Nigeria https://www.researchgate.net/publication/372587622_COVID19_Vaccine_Uptake_and_its_Determinants_Findings_From_A_Web-Based_Survey_in_Nigeria.

[18] Maduka D, Adaobi IO, Henrietta U. Acceptance of malaria vaccine by a rural community in Nigeria. Niger J Med. 2018; 27: 199. doi:10.4103/1115-2613.278781.

[19] Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, Walker DG. Return on investment from childhood immunization in low- and middle-income countries, 2011-20. Health Aff. 2016; 35(2): 199-207.

[20] Pecenka C, Parashar U, Tate JE, et al. Impact and cost-effectiveness of rotavirus vaccination in Bangladesh. Vaccine. 2017; 35(32): 3982-3987.

[21] Letsa TS, Owusu-Agyei S. Community perceptions of a malaria vaccine in the Kintampo districts of Ghana. Malar J. 2013; 12:156. doi:10.1186/1475-2875-12-156.

[22] Mtenga S, Kimweri A, Romore I, et al. Stakeholders’ opinions and questions regarding the anticipated malaria vaccine in Tanzania. Malar J. 2016; 15: 189. doi:10.1186/s12936-016-1209-6.

[23] Dimala CA, Kika BT, Kadia BM, Blencowe H. Current challenges, and proposed solutions to the effective implementation of the RTS, S/AS01 malaria vaccine program in sub-Saharan Africa: a systematic review. PLoS One. 2018; 13(12): e0209744.

[24] Arora N, Anbalagan C, Pannu L. Towards eradication of malaria: is the WHO’s RTS, S/AS01 vaccination effective enough? Risk Manag Healthc Policy. 2021; 14: 1033-1039.

[25] Fran Bodine, (2022), GeoPoll Reports: Parent Perceptions of the Malaria Vaccine in sub-Saharan Africa, https://www.geopoll.com/blog/malaria-vaccine-parent-perceptions/?utm_feeditemid=,utm_device=c,utm_term=,utm_source=google,utm_medium=ppc,utm_campaign={utmcampaign},hsa_cam=13471823478,hsa_grp=123134039453,hsa_mt=,hsa_src=g,hsa_ad=5
27037284790,hsa_acc={97673848},hsa_net=adwords,hsa_kw=,hsa_tgt=dsa-39587879683&utm_feeditemid=&utm_device=c&adgroupid=123134039453&utm_term=&utm_source=googleb2badsutm_medium=cpc&utm_medium=ppc&utm_campaign={b2b_Dynamic_Ads}&utm_content=527037284790&hsa_cam=13471823478&hsa_grp=123134039453&hsa_mt=&hsa_src=g&hsa_ad=527037284790&hsa_acc=9672540637&hsa_net=adwords&hsa_kw=&hsa_tgt=dsa-39587879683&hsa_ver=3&gclid=Cj0KCQjwrfymBhCTARIsADXTabl3ODXXGzlmRQw1cfGLkS8XKaUZ3A5IsNhi7r5qEyZ3YTCBzWxR-44aApILEALw_wcB.

[26] Adjei, M.R., Amponsa-Achiano, K., Okine, R. et al. Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021. BMC Public Health 23, 586 (2023). https://doi.org/10.1186/s12889-023-15481-6.